Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chondrosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00334854
What this trial is testing

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
European Paediatric Soft Tissue Sarcoma Study Group 250
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00002515
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06127407
What this trial is testing

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Who this might be right for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Servier Bio-Innovation LLC 136
Testing effectiveness (Phase 2)Study completedNCT02389244
What this trial is testing

A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Who this might be right for
Ewing SarcomasChondrosarcomasOsteosarcomas+2 more
UNICANCER 163
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Not applicableLooking for participantsNCT07315542
What this trial is testing

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

Who this might be right for
ChondrosarcomasCartilage Tumours
St. Anne's University Hospital Brno, Czech Republic 300
Not applicableStudy completedNCT01449149
What this trial is testing

Proton Radiation for Chordomas and Chondrosarcomas

Who this might be right for
ChordomasChondrosarcomas
Abramson Cancer Center at Penn Medicine 54
Testing effectiveness (Phase 2)Ended earlyNCT00543712
What this trial is testing

PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Who this might be right for
Chondrosarcoma
Genentech, Inc. 15
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Study completedNCT01330966
What this trial is testing

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Who this might be right for
ChondrosarcomaMetastatic Chondrosarcoma
Emerald Clinical Inc. 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108
What this trial is testing

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Who this might be right for
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT04867421
What this trial is testing

Neutrophils in Bone Sarcomas

Who this might be right for
Osteosarcoma, Chondrosarcoma
Université de Reims Champagne-Ardenne 25
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableStudy completedNCT02996747
What this trial is testing

Low Grade Chondrosarcoma Versus Enchondroma

Who this might be right for
ChondromaChondrosarcoma
Istituto Ortopedico Rizzoli 102
Testing effectiveness (Phase 2)Looking for participantsNCT04305548
What this trial is testing

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Who this might be right for
Mesenchymal Chondrosarcoma
Italian Sarcoma Group 16
Not applicableNot Yet RecruitingNCT06029478
What this trial is testing

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Who this might be right for
Chondrosarcoma
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Looking for participantsNCT01659203
What this trial is testing

Proton or Photon RT for Retroperitoneal Sarcomas

Who this might be right for
Retroperitoneal Sarcoma
Massachusetts General Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Next Page